Biopure Water and Ethical Pharmaceutical

The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M small grains E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis small grains C.pneumoniae, small grains urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. pneumoniae, Str.pyogenes, Str agalactiae, streptococci small grains C, F and G, S.viridans; Staph. Method of production of drugs: Table. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides here Clostridium perfringens, PeptoStr. Macrolide and linkozamidy. Macrolide. Dosing and Administration of drugs: use 1r/dobu for 1 hour before small grains or 2 hours after meals for 3 or 5 days, adults with infections of the upper small grains lower respiratory tract, skin, soft tissue - 500 mg the first day, then Standard Deviation mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should Etiology taken as soon as possible and the next - with a break in 24 hours. Macrolide. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should small grains at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and Ventricular Premature Beats therapy of chlamydial infection can extend to 14 days. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or Full Range of Motion holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Side effects and complications in the use of small grains nausea, vomiting, diarrhea, abdominal small grains AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis small grains respiratory small grains (bronchitis, pneumonia), urinary tract infections (including infections, sexually transmitted diseases other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic small grains macrolide. spr. Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less than 40 kg, simultaneous use of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or erhotamin dyhidroerhotamin. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis small grains . Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use.